Skip to Content
Merck
CN
  • SIRT6-CBP-dependent nuclear Tau accumulation and its role in protein synthesis.

SIRT6-CBP-dependent nuclear Tau accumulation and its role in protein synthesis.

Cell reports (2021-04-29)
Miguel Portillo, Ekaterina Eremenko, Shai Kaluski, Alfredo Garcia-Venzor, Lior Onn, Daniel Stein, Zeev Slobodnik, Adam Zaretsky, Uwe Ueberham, Monica Einav, Martina K Brückner, Thomas Arendt, Debra Toiber
ABSTRACT

Several neurodegenerative diseases present Tau accumulation as the main pathological marker. Tau post-translational modifications such as phosphorylation and acetylation are increased in neurodegeneration. Here, we show that Tau hyper-acetylation at residue 174 increases its own nuclear presence and is the result of DNA damage signaling or the lack of SIRT6, both causative of neurodegeneration. Tau-K174ac is deacetylated in the nucleus by SIRT6. However, lack of SIRT6 or chronic DNA damage results in nuclear Tau-K174ac accumulation. Once there, it induces global changes in gene expression, affecting protein translation, synthesis, and energy production. Concomitantly, Alzheimer's disease (AD) case subjects show increased nucleolin and a decrease in SIRT6 levels. AD case subjects present increased levels of nuclear Tau, particularly Tau-K174ac. Our results suggest that increased Tau-K174ac in AD case subjects is the result of DNA damage signaling and SIRT6 depletion. We propose that Tau-K174ac toxicity is due to its increased stability, nuclear accumulation, and nucleolar dysfunction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Papain from papaya latex, buffered aqueous suspension, 2× Crystallized, ≥16 units/mg protein
Sigma-Aldrich
Anti-BrdU antibody, Mouse monoclonal, clone BU-33, purified from hybridoma cell culture